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Abstract
The 13th meeting of the Signal Transduction Society was held in Weimar, from October 28 to 30, 2009. Special
focus of the 2009 conference was “Aging and Senescence”, which was co-organized by the SFB 728 “Environmen-
tally-Induced Aging Processes” of the University of Düsseldorf and the study group ‘Signal Transduction’ of the Ger-
man Society for Cell Biology (DGZ). In addition, several other areas of signal transduction research were covered
and supported by different consortia associated with the Signal Transduction Society including the long-term asso-
ciated study groups of the German Society for Immunology and the Society for Biochemistry and Molecular Biol-
ogy, and for instance the SFB/Transregio 52 “Transcriptional Programming of Individual T Cell Subsets” located in
Würzburg, Mainz and Berlin. The different research areas that were introduced by outstanding keynote speakers
attracted more than 250 scientists, showing the timeliness and relevance of the interdisciplinary concept and
exchange of knowledge during the three days of the scientific program. This report gives an overview of the pre-
sentations of the conference.
The scientific program of the 13th annual conference of
the Signal Transduction Society started with a workshop
on Immune Signaling that was co-organized by the
study group ‘Signal Transduction” of the German
Society for Immunology and The SFB/Transregio 52
“Transcriptional Programming of Individual T Cell Sub-
sets” with scientists from Würzburg, Mainz and Berlin.
The introductory keynote lecture was given by Arthur
Weiss from the Howard Hughes Medical Institute in
San Francisco, CA, the past president of the American
Association of Immunology (AAI) and an outstanding
pioneer of T cell signal transduction research. Professor
Weiss discussed the requirements and properties of
inhibitors of protein tyrosine kinases for their clinical
use. In particular, he reported that certain inhibitors
induce quite dramatic and relevant conformational
changes in the key tyrosine kinase ZAP-70 that alter the
accessibility of the molecule and regulate the state of
activation be fine-tuning intra- and intermolecular pro-
tein-protein interaction.
Following the STS tradition, the workshop was contin-
ued by short presentations selected from the more than
120 submitted abstracts. Dirk Mielenz (University of
Erlangen-Nuremberg) introduced Swiprosin-1/EFhd2, a
scaffold protein that for example enables the recruit-
ment of the Syk kinase and other signal transducers
such as PLCg2 to B cell receptor associated lipid raft
areas.
Sonja Reißig (University Hospital Mainz) discussed the
function of the tumor suppressor gene CYLD in T cell
development and NF-B mediated signaling of T cells
highlighting that the expression of a short splice variant
CYLD
ex7/8 in mice leads to reduced numbers of CD8
+
and CD4
+ T lymphocytes in the thymus and the periph-
ery and thereby indicating that CYLD seems to be rele-
vant for the developing T cell compartment. * Correspondence: entschladen@uni-wh.de
1Institute of Immunology, Witten/Herdecke University, Germany
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(NFATc1) in B cell receptor signaling was analyzed by
Jolly Deb (University of Würzburg) who demonstrated
that an inactivation of NFATc1 leads to increased acti-
vation induced cell death (AICD) also in the B cell
compartment.
The second part of the Immune Signaling Workshop
started with a keynote presentation given by Anjana Rao
from the Dana-Farber Cancer Institute at Harvard Med-
ical School, Boston. She reported novel insights into the
function of Foxp3 related to its binding properties as
well as suppressive abilities. The DNA-binding sites in
the forkhead domain of Foxp2 differ from those of
Foxp3 in three amino acids. If these variant residues are
introduced into Foxp3 and the resulting mutant protein
is over-expressed in cell lines, the suppressive activity
but not DNA binding of Foxp3 is abrogated. Moreover,
these residues are important for Foxp3 dimer formation
that bridges two molecules of DNA. Introduction of
structure-guided mutations in the domain-swapping
interface of Foxp3 specifically disrupted this dimer for-
mation and impaired the suppressor function on retrovi-
rally-transduced T cells but compromised the ability of
Foxp3 to bind to DNA. Further evaluation will show
whether the Foxp3-mediated long-range interactions in
DNA may contribute in part to the gene regulation by
Foxp3 in regulatory T cells.
Related to this topic, Matthias Klein and colleagues
(University of Mainz) discussed the role of the Ikaros
transcription factor Helios in regulatory T (Treg) cells.
Helios is highly expressed in Treg cells and is not a tar-
get of Foxp3 but rather promotes Foxp3 expression.
Thus, Helios may play a role in Treg cell induction and
function.
Thomas Oellrich and colleagues (University of Göttin-
gen) demonstrated the great potential of a functional
proteomic approach to characterize the basal state and
the kinetics of signaling modules after signal processing.
They elucidated the functional interactomes of the adap-
ter protein SLP-65 and its regulation by BCR signaling.
They combined three techniques: identification of mole-
cules in signaling complexes by stable isotope labeling
with amino acids in cell culture (SILAC), analysis of the
affinity-purified molecules by mass spectrometry, and
evaluation of the functionality of the molecules by muta-
tional reconstitution studies. This approach seems to be
promising in studying checkpoints of BCR and TCR sig-
naling in general.
Markus Lettau and colleagues (University of Kiel) have
been interested in the identification of interaction part-
ners for the intracellular N-terminal region of Fas ligand
that might be generated by proteolytic shedding during
T cell activation. Using the phage display technique,
they identified several potential binding proteins
including tyrosine kinases and different families of adap-
tor proteins including PCH proteins and sorting nexins.
The differential binding of individual interactors to the
full length Fas ligand protein and/or the N-terminal
fragments might indicate a regulatory capacity of the
proteolytically processed FasL N-terminus.
The workshop Growth Factors, Cytokines and Chemo-
kines started with a presentation of the keynote speaker
Ivo Touw (Erasmus University Medical School Rotter-
dam) about the granulocyte colony stimulating factor
receptor (GCSFR). For this receptor, a tight interplay
between receptor routing and signal transduction could
be demonstrated: Upon GCSF stimulation and endocy-
tosis, the receptor becomes ubiquitinylated at lysine 632
in a SOCS3-dependent manner. This ubiquitinylation is
responsible for the lysosomal targeting and degradation
of the receptor. Mutation of lysine 632 leads to pro-
longed activation of STAT5 and Erk (as long as there is
no other, substituting lysine residue present in the
juxta-membrane region), but not of protein kinase B.
Novel data show that GCSF quickly leads to the expres-
sion of a deubiquitinylating enzyme (DUB2A) which can
counteract the SOCS3-mediated ubiquitinylation and
thereby stabilize the GCSFR in early endosomes. More-
over, GCSF signaling is affected by radical oxygen spe-
cies. Most interestingly, the C-terminal part of the
GCSFR can interact with an ER-resident peroxiredoxin
(PRDX4). According to the current working model, the
internalized receptor transits the ER where PRDX4 may
act to prevent the inactivation of redox-sensitive phos-
phatases and thereby favor dephosphorylation events
leading to the termination of signal transduction.
Heike M. Hermanns (Rudolf-Virchow-Center, Univer-
sity of Würzburg) gave a short presentation about the
significant involvement of Oncostatin M (OSM) in rheu-
matoid arthritis. OSM, but not IL-6 or TNFa,c a ns t i -
mulate the expression of the chemokine CCL13 in
synovial fibroblasts, but not in other types of fibroblasts
or chondrocytes. STAT5, Erk1/2 and p38 are involved
in the OSM-dependent transcription and mRNA stabili-
zation of CCL13. CCL13 was discovered in the synovial
fluid of patients with rheumatoid arthritis (RA) and sti-
mulates the migration of monocytes. Interestingly, syno-
vial fibroblasts of RA patients constitutively produce
CCL13, which is partially dependent on endogenous
OSM production.
Ignacio Rubio (University of Jena) developed a novel
high avidity probe for RasGTP which can be used to
monitor Ras activity as well as its subcellular distribu-
tion. It is composed of three copies of GFP and three
copies of the Ras binding domain of Raf. In contrast to
previously developed Ras probes, this novel construct is
able to decorate endogenous RasGTP. Using the novel
probe to image Ras activation by the T cell receptor,
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the sole site of Ras activation in life T-cells.
TAK1, an important upstream kinase in the signaling
pathways involving IL-1, TNF, or toll-like receptors, is
controlled by the regulatory subunit TAB1. Alexander
Wolf (University of Giessen) reported novel phosphory-
lation sites within the C-terminal cluster of six serine
residues of TAB1. The phosphorylation can be mediated
by TAK1 as well as by p38 MAPK and seems to affect
the activity and localization of p38 MAPK.
The data presented by Katharina Rzeczkowski (Uni-
versity of Giessen) point at an exciting novel role of
JNK in post-transcriptional events: argonaute 2 (Ago2),
the essential catalytic subunit of the RISC complex, is a
binding partner of JNK. A potential role of JNK in
miRNA regulation is implied by an altered miRNA
expression in JNK-deficient cells and by an altered bind-
ing pattern of certain miRNAs in Ago2/JNK complexes
upon JNK phosphorylation. Moreover, Ago2 and JNK
colocalize in cytoplasmic processing (P)-bodies together
with the decapping complex subunit DCP1a which was
further demonstrated to be a JNK substrate. JNK activity
affected the number and size of DCP1a-containing RNP
particles. These data suggest that JNK participates in the
regulation of mRNA processing.
Among the six short presentations of the second part
of the workshop on Growth Factors, Cytokines and
Chemokines two talks addressed novel aspects of CD95/
Fas mediated signaling. Inna Lavrik from the group of
Peter Krammer (Division of Immunogenetics, DKFZ
Heidelberg) used a systems biology approach to under-
stand the life and death decisions mediated by CD95
(Fas, APO-1) in quantitative terms. Using HeLa cells
which overexpress various components of the CD95 sys-
tem they showed both apoptotic and non-apoptotic
pathways depending on the concentration of the CD95
death-inducing signaling complex (DISC) components.
Single-cell and population-based measurements resulted
in a mathematical model which takes into account the
complex interplay between various death effector
domain (DED)-containing proteins. The application of
this model has demonstrated how exact concentrations
of c-FLIP and procaspase-8 and their cleavage products
at the DISC can determine life/death decisions.
Ottmar Janssen (University of Kiel) highlighted the
dose-dependent modulation of CD4 T-cell responses by
CD95 co-stimulation. They confirmed that CD95 can
exert anti-apoptotic activities under certain conditions.
High doses of CD95 agonists completely abrogated
CD3/CD28-triggered T-cell proliferation without indu-
cing cell death. Early as well as late signaling events
were equally impaired. In contrast, lower doses drasti-
cally augmented CD3-induced cell proliferation which
was due to co-internalization of the receptors and
sustained activation of signaling components (MAP
kinases, caspases, NF-B and cell cycle components)
and resulted in upregulation of various activation mar-
kers (adhesion molecules, cytokine receptors, cytokines).
The group of Stefanie Kliche (University of Magde-
burg) investigated the role of the adapter protein SLP76
(SH2 domain containing leukocyte-specific phosphopro-
tein of 76 kDa) in T-cell receptor (TCR) and chemokine
receptor (CXCR4) signaling, both of which are crucial
for adhesion and migration of T-cells. They identified
the mandatory function of SLP76 in TCR-mediated
inside-out signaling, where it facilitates the membrane
recruitment of the ADAP/SKAP55/RIAM/Rap1 module
and controls the Rac-mediated actin polymerization.
Surprisingly, CXCR4-mediated T-cell adhesion and
migration was not affected by the loss of SLP76 imply-
ing a differential role for this adapter protein in TCR-
and CXCR4-mediated inside-out signaling.
Yaw Asare from the group of Jürgen Bernhagen
(RWTH Aachen) demonstrated a novel role of the
COP9 signalosome (CSN) in NF-B signaling in athero-
genesis. Silencing CSN5/JAB1, a critical subunit of the
COP9 complex and responsible for the cullin-1 deNED-
Dylation activity of CSN, resulted in an enhanced
expression of the inhibitor of B( I Ba). In the context
of inflammatory or pro-atherogenic conditions CSN5 or
CSN2 knockdown increased the TNFa-mediated phos-
phorylation of IKK and NF-B which might be indica-
tive of a vital role of CSN in the canonical NF-B
pathway.
Meike Jung also from the group of Jürgen Bernhagen
addressed the signaling and function of the cytokine
MIF (macrophage migration inhibitory factor) in liver
fibrogenesis. To this end they compared mif
-/-with wild-
type mice in the CCl4- and the thioacetamide-induced
fibrosis model. Immunohistochemical analysis as well as
evaluation of fibrosis markers revealed a stronger fibro-
tic response in mif
-/-mice. This suggested an unexpected
protective role of MIF during the progression of liver
fibrosis.
Finally, the group of Iris Behrmann (Life Sciences
Research Unit, University of Luxemburg) identified a
novel physiological function of the interleukin-6-type
cytokine oncostatin M. In hepatocytes and hepatoma
cells this cytokine upregulated the expression of
hypoxia-inducible factor-1a (HIF-1a). This protein is
most often regulated on the level of protein stability;
however, here it was clearly shown that increased
expression of HIF-1a in response to OSM did not result
from protein stabilization but from increased transcrip-
tion. Behrmann et al. identified the Jak/STAT3- and
MEK/Erk1/2-pathways as crucial signaling components
important for OSM-induced HIF-1a transcription and
consequently for the enhanced expression of VEGF and
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between cytokine and hypoxia signaling in liver develop-
ment or regeneration.
The workshop Migration, Adhesion and Intercellular
Signalling started with a keynote lecture by Stephen
Ward (University of Bath, UK), who highlighted the
essential role of phosphytatidylinositol-3-kinases (PI3K)
in the polarization and migration of leukocytes in
inflammation and autoimmune diseases. He discussed
the potential use of PI3K inhibitors, and showed that
alternatively an activation of the antagonistic phospha-
tase SHIP (SH2-containing inositol-5-phosphatase)
might provide a target of hematopoietic and immune
disorders in which the PI3K pathway is dysregulated.
The targets of phosphoinositides were the topic of
Kerstin Tang’s (Charité, Berlin) presentation. She pro-
vided evidence that the a1b1 integrin, a receptor for
collagens and laminin1, which is important for cell
migration, interacts with phosphoinositides, especially
with phoaphatidylinositol 4,5-bisphosphate and phos-
phatidylinositol 3,4,5 trisphosphate, via its positively
charged cytoplasmic which consists of only 15 amino
acids. Binding of the integrin to the negatively charged
phosphoinositides of the plasma membrane might be an
early event, which is important for the regulation of
integrin affinity and subsequently, for the modulation of
cell migration.
Michal Smida (University of Magdeburg) presented
results on the identification of a novel GTPase-activat-
ing protein, which they termed IGAP (inducible
GTPase-activating protein), since this protein is upregu-
lated upon T cell activation. The targets of IGAP are
the GTPases Rac and Cdc42, but not Ras and Rap1. He
proposed that the upregulation of IGAP in activated T
cells serves to regulate their activation status.
Thomas Vogl (University of Münster) described the
function of the calcium-binding protein complex
S100A8/S100A9 in the migration of leukocytes. He dis-
cussed data on the interaction of this complex with
microtubules and the regulation of the dynamic beha-
vior of microtubules. The S100A8/S100A9 complex is
also known as calprotectin, which is secreted by phago-
cytes during stress response as an endogenous activator
of the toll-like receptor 4.
The scientific part of the session on Migration, Adhe-
sion and Intercellular Signalling closed with a presenta-
tion by Otmar Huber (University of Jena) elucidating
that the transcriptonal activity of the estrogen receptor
(ER) is enhanced by b-catenin. He described the canoni-
cal Wnt-signaling and further modulators of ER activity
in anchorage-dependent growth of cancer cells.
Bacterial and viral strategies to modulate host cell sig-
naling are a constantly expanding field of research and
were the main topic of the workshop on Pathogens and
Disease. Pathogenic microbes and viruses exploit cellular
signaling pathways to establish a successful infection and
to block or evade the host’s defense mechanisms against
the invader. In his keynote presentation, Michael Nau-
mann (University of Magdeburg) reviewed current
knowledge on immunomodulatory functions of patho-
gens, exemplified by bacterial and viral mechanisms tar-
geting the NF-B pathway, a crucial coordinator of the
innate and adaptive immune response. Many compo-
nents of the NF-B pathway are regulated at the post-
transcriptional level by secondary modifications through
ubiquitin (Ub) or ubiquitin-like modifiers (Ubl) such as
Nedd8 or SUMO. Although bacteria themselves do not
possess an Ub or Ubl system, it was found recently that
bacterial pathogens express deubiquitinating enzymes
(DUBs) to modulate the NF-Bs y s t e mo ft h eh o s t ,
which is a pivotal example of co-evolution of the host
and its pathogens. For instance, Chlamydia trachomatis,
a human pathogen that causes various human diseases
including blindness, evades the host inflammatory
response by expressing the deubiquitinating ChlaDub1
protein that inhibits I-B ubiquitination and, thus, NF-
B activation. Modulation of the host’s Ub-system likely
constitutes a general strategy used by many pathogens
because some viruses encode DUBs as well. A newly
described example is the Kaposi’s sarcoma-associated
herpesvirus (KSHV) Orf64 DUB, which possesses target
specificity towards Lys 48 or Lys 63-linked ubiquitin
chains.
Dagmar Hildebrand and colleagues (University of Hei-
delberg) presented data on the mitogenic protein toxin
PMT from toxigenic Pasteurella multocida strains. After
their initial observation that PMT is capable of blocking
the apoptotic effects of the omnipotent kinase inhibitor
staurosporine, Dagmar Hildebrand and co-workers
investigated the mechanism of this signaling pathway.
They found that two serine/threonine kinases are
involved, as PMT leads to STAT-dependent induction
of Pim-1 expression and PI3K-dependent Akt activation.
Selective inhibition of both kinases was necessary and
sufficient to re-sensitise cells for staurosporine.
Mauro Togni (University of Magdeburg) and collea-
gues investigated the mechanisms enabling immune
cells to eliminate intracellular pathogens such as Listeria
monocytogenes. They found that mice deficient for the
cytosolic adapter molecule SKAP-HOM have a reduced
potential to clear the pathogen. Subsequently, they iden-
tified a role of SKAP-HOM in signal transduction of
dendritic cells (DC). Although SKAP-HOM-deficient
DCs were able to transduce toll-like receptor (TLR)-
mediated signals, these cells showed reduced actin poly-
merization, downregulation of proteins involved in
cytoskeletal rearrangement, such as cofilin or Pyk2, and
an upregulation of pSTAT5 levels upon pathogen
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number of CD8
+ T cells and incomplete pathogen clear-
ance in vivo. The data from Togni et al. therefore sug-
gest that not only pathogen recognition through TLRs
but also intercellular signaling via integrins plays an
important role in the efficient activation of the adaptive
immune system.
Signalling mechanisms of herpesviral oncoproteins
were the focus of the two talks on viral pathogens.
Anna Shkoda and colleagues (Helmholtz Center
Munich) reported a novel experimental strategy by
which they were able to identify new components of the
signaling complex of the latent membrane protein 1
(LMP1) of Epstein-Barr virus (EBV) in EBV-transformed
primary human B-lymphocytes. Using subtractive pro-
teomics they have characterized a member of the STE20
family of germinal center kinases with so far largely
unknown functions in hematopoietic cells as a novel
interaction partner of the LMP1 complex. Data were
presented demonstrating that interaction of this kinase
with the very C-terminus of the LMP1 signaling domain
is mediated by TRAF6, a critical signaling mediator of
LMP1 and cellular members of the TNF-receptor and
TLR families. RNAi experiments finally proved that this
STE20 kinase is essential for LMP1 activation of the cel-
lular JNK pathway, which is required for host cell trans-
formation by LMP1.
I nt h el a s tp r e s e n t a t i o no ft h es e s s i o no nP a t h o g e n s
and Disease, Stefan Richter (University Hospital Erlan-
gen) reported on a newly identified cross-talk of the
herpesvirus saimiri (HVS) oncoprotein Tip (tyrosine
kinase interacting protein) with death receptor signaling
in Jurkat cells as well as in HVS-transformed human T-
cells. Tip activates pro-apoptotic caspases via a Fas- and
TRAIL-independent mechanism. Notably, Tip seems to
subvert and, thereby, exploit death receptor signaling
pathways for cell transformation because Tip-expressing
cells were protected from apoptosis. The precise under-
lying molecular mechanism of this effect is currently
under investigation.
The special focus topic of the 2009 meeting of the Sig-
nal Transduction Society was Aging. The first of the two
workshops on Aging was devoted to Mechanisms and
Biomarkers of Aging. Two keynote presentations high-
lighted the two foci set by the title of the session: Alexan-
der Bürkle (University of Konstanz) introduced a novel
project funded by the EU commission, MARK-AGE, that
is designed as a population study serving the purpose of
identifying biomarkers of aging that may be applied as a
set of parameters in order to estimate an individual’s bio-
logical age. One of the goals is to enhance the predict-
ability of the onset of age-related diseases.
Jose Viña (University of Valencia, Spain) presented
data on the identification of novel longevity-associated
genes, including p53/p16 and guanosine releasing factor
1 (GRF1). While the presence and activity of p53 was
demonstrated to enhance longevity by upregulating the
expression of potent antioxidants, the sestrins, life span
is enhanced by the loss of GRF1, which is accompanied
by a downregulation of IGF1. Current research aims at
identifying physiological approaches inducing changes in
expression of longevity-associated genes.
Age-related damage to biomolecules can serve as
potential biomarker for aging and may also be causative
in bringing about the very changes observed in cellular
metabolism and tissue integrity during senescence. Two
variations on that theme were presented by Andreas
Simm (University of Halle-Wittenberg) and Rudolf
Wiesner (University of Cologne): The accumulation of
advanced glycation endproducts not only serves as a
potential biomarker of aging but glycation of platelet-
derived growth factor (PDGF) was demonstrated by
Simm et al. to impair PDGF signaling, with potential
implications for physiological processes such as wound
healing. Wiesner et al., on the other hand, demonstrated
that damage to a different type of biomolecule, mito-
chondrial DNA (mtDNA), not only accumulates during
aging and in age-related pathologies, but may be
enhanced by the turnover and metabolism of well-
known signaling molecules, catecholamines. Accumula-
tion of damage to mtDNA will result in impaired mito-
chondrial metabolism and activity that may, in turn,
foster the development of age-related changes in tissues.
The second part of the special focus theme Aging had
the topic DNA Damage Repair and Aging. In the key-
note lecture, Ian D Hickson (University of Oxford, UK)
introduced the ReqQ helicase family, which is required
for the maintenance of genomic stability and thus serves
important functions in the prevention of cancer. The
role of these proteins in aging was underscored by the
fact that a compromised function of different RecQ heli-
cases in several human genetic disorders does not only
lead to cancer predisposition, but also to various proger-
ias, among them Bloom’s and Werner’s syndrome.
The talk by Marc Majora (IUF, Düsseldorf) described
an interesting phenotype of mice deficient in the CSB
protein, which is part of the transcription-coupled repair
(TCR) pathway. The knockout of CSB led to increased
papilloma formation, but unexpectedly resulted in pro-
tection against UV-induced carcinogenesis. This indi-
cates opposite functions of TCR in photoaging and
photocarcinogenesis in the skin.
Cornelia Dietrich (University Medical Center, Mainz)
described beneficiary roles of dietary ligands of the aryl
hydrocarbon receptor (AhR), which is known to mediate
toxic effects of many environmental pollutants, e.g.
dioxin. A metabolic product of brassica vegetables was
shown to protect against oxidative DNA damage.
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approaches to analyze the processes underlying cellular
and organismic aging ranging from biochemical and cell
culture studies to in vivo analyses in different animal
model systems. Susanne Jennek, (Jena University Hospi-
tal) presented a proteomic approach directed at identify-
ing interaction partners of the p33
ING1B protein, which
can induce premature senescence in primary human
fibroblasts.
Under the aspect that mitochondrial dysfunction is
observed during aging, Kim Zarse (University of Jena)
showed in Caenorhabditis elegans that a transient
increase in mitochondrial ROS formation can potentiate
the life span extension observed when the Insulin/IGF-I
signaling pathway is impaired.
Nicole Büchner (IUF, Düsseldorf) described non-
nuclear functions of the catalytic subunit of telomerase,
telomerase reverse transcriptase (TERT). TERT was
shown to be present in mitochondria, where it protected
mitochondrial DNA against damage and improved mito-
chondrial function in cell culture and in vivo.
Michael Graf (Leibniz Institute for Age Research, Jena)
introduced a new animal model system in aging
research, the fastest aging vertebrate known thus far, the
annual killifish Nothobranchius furzeri,w h i c hh a sb e e n
established as a laboratory animal only during the last
few years.
This year’s session on recent advances in Tumor Biol-
ogy was introduced by Stefan Knapp (University of
Oxford, UK) who gave an overview on new insights into
kinase regulation and kinase inhibition resulting from
high-throughput ultrastructural experiments. Many
kinases have been linked to disease development and sev-
eral of them are validated intervention points for inhibi-
tor and drug development. However, clinical trials
demonstrate that kinase inhibitors are often not as speci-
fic as desired leading to unwanted side effects. The group
of Stefan Knapp described more than 50 novel catalytic
domain structures and kinase inhibitor complexes and
identified novel structural motifs that represent a valu-
able structural genomics platform for drug design and
development. In his talk he also presented recent results
on kinase regulation and auto-activation especially con-
centrating on calcium calmodulin-dependent kinases.
Christina Zechel (University Hospital of Schleswig-
Holstein) focused in her talk on the responsiveness of
primary cultures of stem cell-like brain tumor cells to
mitogens. The presented data indicate that neural stem
cell (NSC)-like cells within malignant brain tumors sup-
port the growth of tumor cells by paracrine mechan-
isms. Moreover, NSC-like cells themselves respond to
mitogens, such as EGF, bFGF or PDGF.
T h er o l eo ft h et r a n s c r i p t i o nf a c t o rN F A Ti nT - c e l l
acute lymphoblastic leukaemia (T-ALL) was introduced
by Martin R. Müller (University of Tübingen). Experi-
ments in NIH/3T3 mouse fibroblasts demonstrated that
constitutive active NFAT1 and NFAT2 exhibit opposite
effects on proliferation and cell growth. NFAT2 pro-
motes proliferation and growth whereas NFAT1 sup-
presses cell growth and proliferation. By using a T-ALL
transgenic mouse model expressing hyperactive NFAT1
in T cells the tumor suppressive function of NFAT1 was
affirmed thereby emphasizing the importance of the
NFAT signaling pathway in the pathogenesis of
leukemia.
The regulation of a second family of transcription fac-
tors of special relevance in T lymphocytes, namely NF-
B, was addressed by Sarah Jill de Jong (University
Erlangen-Nuremberg). The Herpesvirus ateles Tl y m -
photropic oncoprotein “two-in-one” (Tio) is a mem-
brane-bound protein which forms homodimers or
multimers. Tio markedly induced NFB in T cells by
TRAF6- and Nemo-dependent pathways and it initiated
the processing of active p52 independent of the canoni-
cal NF-B signal. Thus, Tio might be a unique tool to
study non-canonical NF-B signaling in T cells.
The important topic of cancer cell invasiveness was
addressed by Gerald Radziwill (University of Freiburg).
The scaffold protein CNK1 mediates proliferative as
well as antiproliferative responses and was described to
be involved in protooncogenic signaling pathways. G.
Radziwill demonstrated that CNK1 is localised at the
plasma membrane in breast carcinoma cells where it
supports cell proliferation in a phosphatdylinositiol-3-
kinase (PI3K)-Akt-FoxO-dependent manner and induces
tumor cell invasiveness in a NF-B-dependent mode.
Hence, CNK1 might be an essential mediator of onco-
genic signaling in breast carcinoma cells and a new tar-
get in cancer therapy.
Concluding remarks
The 2009 meeting of the Signal Transduction Society
brought together a vivid community of scientists work-
ing on distinct aspects of signal transduction, but often
benefiting a common basis of emerging tools and
approaches, which enabled a productive exchange of
new tricks of the trade and fostered many new and
sometimes interdisciplinary collaborations. The 2010
conference will be held again in Weimar from 18 to 20
October. The special focus topic for 2010 will be “Drug
Design/Drug Discovery”.
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